Skip to main content

Advertisement

Log in

The role of prices in drug expenditure analysis

An application of price indexes for two therapeutic groups in the Catalan Health Service (1991–1999)

El papel de los precios en el análisis del gasto en medicamentos. Una aplicación de índices de precios para dos grupos terapéuticos en la sanidad catalana (1991–1999)

  • Original papers
  • Published:
The European Journal of Health Economics (HEPAC) Aims and scope Submit manuscript

Abstract

The objective of this article is to develop and apply several types of price indexes to the analysis of pharmaceutical expenditure to improve the way traditional indexes adjust for innovation in drug supply. The Laspeyres and Paasche indexes in the fixed and linked modalities were used. Price is defined as average expenditure at consumer price per daily defined dose (DDD). The empirical application is restricted to two therapeutic groups, antipsychotics and antidepressants, and to the pharmaceutical expenditure of the Catalan Health Service in the period 1991–1999. The indexes can be computed from the information currently recorded in the administrative procedures of health care insurers, or from sample information provided by regular market surveys. The proposed method allows for controlling the effect of several factors on average pharmaceutical price changes, specifically, the introduction of new drugs that show some degree of therapeutic innovation.

Resumen

El objetivo de este trabajo es desarrollar índices de precios de medicamentos que permitan separar el efecto de distintos factores, especialmente la comercialización de nuevos medicamentos que suponen distintos grados de innovación terapéutica, sobre los incrementos de precios y sobre el gasto. Se han utilizado los índices de Laspeyres y de Paasche en sus versiones fija y encadenada, tomando como precio el gasto medio a PVP (Precio de Venta al Público) por DDD (Dosis Diaria Definida). La aplicación empírica se circunscribe a dos grupos terapéuticos, antipsicóticos y antidepresivos, y al ámbito de la prestación farmacéutica del Servei Català de la Salut en el periodo 1991–1999. Esta metodología puede ser aplicada de forma rutinaria y automática a cualquier grupo terapéutico o a la totalidad de los mismos, utilizando la información que recogen habitualmente las administraciones sanitarias en el proceso de facturación de los medicamentos o la información muestral sobre consumo y gasto de algunos estudios de mercado.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rovira, J., Tremosa, R., Gilabert, A. et al. The role of prices in drug expenditure analysis. HEPAC 2, 142–149 (2001). https://doi.org/10.1007/s101980100071

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s101980100071

Navigation